Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
2G Energy AG

Start price
Target price
Perf. (%)
€86.00
24.03.21
€99.00
24.03.22
-2.44%
20.04.21

Top 10 in its market
Revenue growth >5% per year expected
Sustainability is very important
Significant cyclical dependencies
buy
Psi AG

Start price
Target price
Perf. (%)
€26.60
24.03.21
€30.00
24.03.22
18.05%
28.04.21

Standard Investments for future growth
Innovative
Future proof or reliable business model
Significant cyclical dependencies
buy
Formfactor Inc.

Start price
Target price
Perf. (%)
€37.20
24.03.21
€40.00
24.03.22
7.53%
25.03.22

Could be worthwhile Investment >10% per year
buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€8.12
24.03.21
€10.00
24.03.22
2.77%
06.04.21

Could be worthwhile Investment >10% per year
buy
VBI Vaccines Inc.

Start price
Target price
Perf. (%)
€82.08
24.03.21
€120.00
24.03.22
-5.19%
06.04.21

Could be worthwhile Investment >10% per year
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€53.20
24.03.21
€60.00
24.03.22
30.86%
06.04.21

Could be worthwhile Investment >10% per year
buy
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€6.50
24.03.21
€9.00
24.03.22
-14.00%
06.04.21

Could be very worthwhile Investment >20% year
Gamestop Corp.

Start price
Target price
Perf. (%)
€33.14
24.03.21
-
24.03.22
-15.04%
25.03.21

Risky Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
Little Investments for future growth
buy
HOME24 SE

Start price
Target price
Perf. (%)
€21.30
23.03.21
-
23.03.22
-69.04%
24.03.22

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Market Leader or Top 3
Gamestop Corp.

Start price
Target price
Perf. (%)
€40.76
22.03.21
€13.75
22.03.22
14.59%
08.11.21

Risky Investment
overvalued
Very low/no dividend yield expected
buy
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€564.00
22.03.21
€900.00
22.03.22
-17.45%
03.04.21

Good culture
Capable Management
Could be worthwhile Investment >10% per year
Few uniques
buy
Betsson AB

Start price
Target price
Perf. (%)
€7.37
22.03.21
€8.00
22.03.22
-28.49%
23.03.22

Could be worthwhile Investment >10% per year
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€11.10
22.03.21
-
22.03.22
-20.29%
05.04.21

Could be very worthwhile Investment >20% year
Some uniques
Known brand
buy
HighPoint Resources Corp.

Start price
Target price
Perf. (%)
€4.34
22.03.21
-
22.03.22
7.26%
02.04.21

Risky Investment
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€11.50
21.03.21
-
21.03.22
-23.06%
06.04.21

Risky Investment
Express Inc.

Start price
Target price
Perf. (%)
€4.50
21.03.21
-
21.03.22
-22.22%
06.04.21

Risky Investment
Gamestop Corp.

Start price
Target price
Perf. (%)
€42.87
21.03.21
-
21.03.22
-6.43%
06.04.21

Risky Investment
buy
CD Projekt S.A.

Start price
Target price
Perf. (%)
€49.01
21.03.21
-
21.03.22
-21.05%
22.03.22

Revenue growth >5% per year expected
Good culture
Could be worthwhile Investment >10% per year
Known brand
buy
Gamestop Corp.

Start price
Target price
Perf. (%)
€42.87
21.03.21
-
21.03.22
-49.87%
22.03.22

Deficits in Management
No Innovation
buy
Impac Mortgage Holdings

Start price
Target price
Perf. (%)
€1.85
21.03.21
€2.00
21.03.22
-64.32%
22.03.22

Could be worthwhile Investment >10% per year
buy
Applied Optoelectronics Inc.

Start price
Target price
Perf. (%)
€7.17
21.03.21
-
21.03.22
-57.88%
22.03.22

Risky Investment
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€11.50
21.03.21
-
21.03.22
-64.30%
22.03.22

Could be very worthwhile Investment >20% year
Innovative
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€8.60
20.03.21
€5.00
04.11.21
-31.08%
05.11.21

Risky Investment
Revenue decline > 20% expected
EBIT decline/stagnation expected
Marker Therapeutics Inc.

Start price
Target price
Perf. (%)
€25.00
20.03.21
€10.00
20.03.22
-28.40%
03.04.21

Higher EBIT margin than peer group
Revenue growth >5% per year expected
Fair valuation
positive Cash Flow expected
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€6.14
20.03.21
€3.00
20.03.22
-1.27%
03.04.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group